Julian Druce

InstitutionMelbourne Health at the Peter Doherty Institute for Infection and Immunity
AddressVic
Australia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 26 Covid-19 publications, with a maximum of 4 publications in Spetember 2020
    All Publications
    Bar chart showing 84 publications over 23 distinct years, with a maximum of 14 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Graham M, Ballard SA, Pasricha S, Lin B, Hoang T, Stinear T, Druce J, Catton M, Sherry N, Williamson D, Howden BP. Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context. Pathology. 2021 Oct; 53(6):689-699. PMID: 34425991.
      Citations:    Fields:    Translation:Humans
    2. Citations: 24     Fields:    Translation:Humans
    3. Wood BR, Kochan K, Bedolla DE, Salazar-Quiroz N, Grimley SL, Perez-Guaita D, Baker MJ, Vongsvivut J, Tobin MJ, Bambery KR, Christensen D, Pasricha S, Eden AK, Mclean A, Roy S, Roberts JA, Druce J, Williamson DA, McAuley J, Catton M, Purcell DFJ, Godfrey DI, Heraud P. Infrared Based Saliva Screening Test for COVID-19. Angew Chem Int Ed Engl. 2021 07 26; 60(31):17102-17107. PMID: 34043272.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    4. Riddell S, Goldie S, McAuley AJ, Kuiper MJ, Durr PA, Blasdell KR, Tachedjian M, Druce JD, Smith TRF, Broderick KE, Vasan SS. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets. Front Immunol. 2021; 12:694857. PMID: 34248993.
      Citations: 2     Fields:    Translation:HumansAnimalsPHPublic Health
    5. Nicholson S, Karapanagiotidis T, Khvorov A, Douros C, Mordant F, Bond K, Druce J, Williamson DA, Purcell D, Lewin SR, Sullivan S, Subbarao K, Catton M. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance. Open Forum Infect Dis. 2021 Jul; 8(7):ofab239. PMID: 34258311.
      Citations: 1     
    6. Audsley JM, Holmes NE, Mordant FL, Douros C, Zufan SE, Nguyen THO, Kedzierski L, Rowntree LC, Hensen L, Subbarao K, Kedzierska K, Nicholson S, Sherry N, Thevarajan I, Tran T, Druce J. Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2021 May 10; 1-3. PMID: 33966675.
      Citations:    Fields:    
    7. Hughes CM, Gregory GP, Pierce AB, Druce JD, Catton M, Chong B, Sherry NL, Graham M, Chen M, Salvaris R, Eise N, Lee JYH, McQuilten Z, Crouch S, Looker C, Korman TM, Stuart RL. Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient. Infect Control Hosp Epidemiol. 2021 Mar 19; 1-3. PMID: 33736721.
      Citations:    Fields:    
    8. Bailie CR, Franklin L, Nicholson S, Mordant F, Alpren C, Stewart T, Barnes C, Fox A, Druce J, Subbarao K, Catton M, van Diemen A, Sullivan SG. Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort. Epidemiol Infect. 2021 02 10; 149:e44. PMID: 33563349.
      Citations:    Fields:    Translation:Humans
    9. Williams E, Isles N, Chong B, Bond K, Yoga Y, Druce J, Catton M, Ballard SA, Howden BP, Williamson DA. Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage. J Med Microbiol. 2021 Feb; 70(2). PMID: 33270005.
      Citations: 3     Fields:    Translation:Humans
    10. Bruggink LD, Garcia-Clapes A, Tran T, Druce JD, Thorley BR. Decreased incidence of enterovirus and norovirus infections during the COVID-19 pandemic, Victoria, Australia, 2020. Commun Dis Intell (2018). 2021 Jan 29; 45. PMID: 33573536.
      Citations: 7     Fields:    Translation:HumansCells
    11. Marsh GA, McAuley AJ, Brown S, Pharo EA, Crameri S, Au GG, Baker ML, Barr JA, Bergfeld J, Bruce MP, Burkett K, Durr PA, Holmes C, Izzard L, Layton R, Lowther S, Neave MJ, Poole T, Riddell SJ, Rowe B, Soldani E, Stevens V, Suen WW, Sundaramoorthy V, Tachedjian M, Todd S, Trinidad L, Williams SM, Druce JD, Drew TW, Vasan SS. In vitro characterisation of SARS-CoV-2 and susceptibility of domestic ferrets (Mustela putorius furo). Transbound Emerg Dis. 2021 Jan 05. PMID: 33400387.
      Citations: 3     Fields:    
    12. Citations: 42     Fields:    Translation:Animals
    13. Graham M, Williams E, Isles N, Buadromo E, Toatu T, Druce J, Catton M, Lin C, Howden BP, Williamson DA. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115238. PMID: 33171384.
      Citations: 3     Fields:    Translation:Humans
    14. Moore SC, Penrice-Randal R, Alruwaili M, Randle N, Armstrong S, Hartley C, Haldenby S, Dong X, Alrezaihi A, Almsaud M, Bentley E, Clark J, García-Dorival I, Gilmore P, Han X, Jones B, Luu L, Sharma P, Shawli G, Sun Y, Zhao Q, Pullan ST, Carter DP, Bewley K, Dunning J, Zhou EM, Solomon T, Beadsworth M, Cruise J, Crook DW, Matthews DA, Davidson AD, Mahmood Z, Aljabr W, Druce J, Vipond R, Ng L, Renia L, Openshaw PJM, Baillie JK, Carroll MW, Stewart J, Darby A, Semple M, Turtle L, Hiscox JA. Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism. Viruses. 2020 10 14; 12(10). PMID: 33066701.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    15. McAuley AJ, Kuiper MJ, Durr PA, Bruce MP, Barr J, Todd S, Au GG, Blasdell K, Tachedjian M, Lowther S, Marsh GA, Edwards S, Poole T, Layton R, Riddell SJ, Drew TW, Druce JD, Smith TRF, Broderick KE, Vasan SS. Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein. NPJ Vaccines. 2020; 5:96. PMID: 33083031.
      Citations: 14     
    16. Chong BSW, Tran T, Druce J, Ballard SA, Simpson JA, Catton M. Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings. Pathology. 2020 Dec; 52(7):796-800. PMID: 33036772.
      Citations: 5     Fields:    Translation:Humans
    17. Seemann T, Lane CR, Sherry NL, Duchene S, Gonçalves da Silva A, Caly L, Sait M, Ballard SA, Horan K, Schultz MB, Hoang T, Easton M, Dougall S, Stinear TP, Druce J, Catton M, Sutton B, van Diemen A, Alpren C, Williamson DA, Howden BP. Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020 09 01; 11(1):4376. PMID: 32873808.
      Citations: 53     Fields:    Translation:HumansCellsPHPublic Health
    18. Williams E, Bond K, Chong B, Giltrap D, Eaton M, Kyriakou P, Calvert P, Zhang B, Siwan M, Howden B, Druce J, Catton M, Williamson DA. Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory. Pathology. 2020 Dec; 52(7):754-759. PMID: 32943228.
      Citations: 5     Fields:    Translation:Humans
    19. Ogando NS, Dalebout TJ, Zevenhoven-Dobbe JC, Limpens RWAL, van der Meer Y, Caly L, Druce J, de Vries JJC, Kikkert M, Bárcena M, Sidorov I, Snijder EJ. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J Gen Virol. 2020 09; 101(9):925-940. PMID: 32568027.
      Citations: 122     Fields:    Translation:HumansAnimalsCells
    20. Williams E, Bond K, Isles N, Chong B, Johnson D, Druce J, Hoang T, Ballard SA, Hall V, Muhi S, Buising KL, Lim S, Strugnell D, Catton M, Irving LB, Howden BP, Bert E, Williamson DA. Pandemic printing: a novel 3D-printed swab for detecting SARS-CoV-2. Med J Aust. 2020 09; 213(6):276-279. PMID: 32772375.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    21. Lee JYH, Best N, McAuley J, Porter JL, Seemann T, Schultz MB, Sait M, Orlando N, Mercoulia K, Ballard SA, Druce J, Tran T, Catton MG, Pryor MJ, Cui HL, Luttick A, McDonald S, Greenhalgh A, Kwong JC, Sherry NL, Graham M, Hoang T, Herisse M, Pidot SJ, Williamson DA, Howden BP, Monk IR, Stinear TP. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA. J Med Microbiol. 2020 Sep; 69(9):1169-1178. PMID: 32755529.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    22. Barr IG, Rynehart C, Whitney P, Druce J. SARS-CoV-2 does not replicate in embryonated hen's eggs or in MDCK cell lines. Euro Surveill. 2020 06; 25(25). PMID: 32613937.
      Citations: 10     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    23. Attwood LO, Francis MJ, Hamblin J, Korman TM, Druce J, Graham M. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay. J Clin Virol. 2020 07; 128:104448. PMID: 32460173.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    24. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 06; 178:104787. PMID: 32251768.
      Citations: 559     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    25. Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R, Yoga Y, Naughton W, Taiaroa G, Seemann T, Schultz MB, Howden BP, Korman TM, Lewin SR, Williamson DA, Catton MG. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020 06; 212(10):459-462. PMID: 32237278.
      Citations: 104     Fields:    Translation:HumansCellsPHPublic Health
    26. Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, Tong SYC, Lewin SR, Kedzierska K. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020 04; 26(4):453-455. PMID: 32284614.
      Citations: 418     Fields:    Translation:HumansCellsPHPublic Health
    Druce's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (249)
    Explore
    _
    Co-Authors (341)
    Explore
    _
    Similar People (60)
    Explore
    _